157 related articles for article (PubMed ID: 16597411)
1. [Sphingolipids, vehicle for pathogenic agents and cause of genetic diseases].
Fasano C; Hiol A; Miolan JP; Niel JP
Med Sci (Paris); 2006 Apr; 22(4):411-5. PubMed ID: 16597411
[TBL] [Abstract][Full Text] [Related]
2. Beyond a structural component: sphingolipids in immunology.
Prieschl EE; Baumruker T
Arch Immunol Ther Exp (Warsz); 2000; 48(3):163-71. PubMed ID: 10912620
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipids in infectious diseases.
Hanada K
Jpn J Infect Dis; 2005 Jun; 58(3):131-48. PubMed ID: 15973004
[TBL] [Abstract][Full Text] [Related]
4. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
[TBL] [Abstract][Full Text] [Related]
5. Molecular facets of sphingolipids: mediators of diseases.
Ozbayraktar FB; Ulgen KO
Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220
[TBL] [Abstract][Full Text] [Related]
6. [Sphingolipid-mediated apoptotic signaling pathways].
Cuvillier O; Andrieu-Abadie N; Ségui B; Malagarie-Cazenave S; Tardy C; Bonhoure E; Levade T
J Soc Biol; 2003; 197(3):217-21. PubMed ID: 14708343
[TBL] [Abstract][Full Text] [Related]
7. Update on lipid membrane microdomains.
Schmitz G; Grandl M
Curr Opin Clin Nutr Metab Care; 2008 Mar; 11(2):106-12. PubMed ID: 18301084
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipid signalling and liver diseases.
Marí M; Fernández-Checa JC
Liver Int; 2007 May; 27(4):440-50. PubMed ID: 17403183
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipids: modulators of HIV-1 infection and pathogenesis.
Rawat SS; Johnson BT; Puri A
Biosci Rep; 2005; 25(5-6):329-43. PubMed ID: 16307380
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipids and cell signalling.
Fredman P
J Inherit Metab Dis; 1998 Aug; 21(5):472-80. PubMed ID: 9728328
[TBL] [Abstract][Full Text] [Related]
11. Sphingolipids and cell death.
Morales A; Lee H; Goñi FM; Kolesnick R; Fernandez-Checa JC
Apoptosis; 2007 May; 12(5):923-39. PubMed ID: 17294080
[TBL] [Abstract][Full Text] [Related]
12. A view on sphingolipids and disease.
Kolter T
Chem Phys Lipids; 2011 Sep; 164(6):590-606. PubMed ID: 21570958
[TBL] [Abstract][Full Text] [Related]
13. Sphingolipids and neuronal degeneration in lysosomal storage disorders.
Grassi S; Chiricozzi E; Mauri L; Sonnino S; Prinetti A
J Neurochem; 2019 Mar; 148(5):600-611. PubMed ID: 29959861
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipid metabolites in neural signalling and function.
Colombaioni L; Garcia-Gil M
Brain Res Brain Res Rev; 2004 Nov; 46(3):328-55. PubMed ID: 15571774
[TBL] [Abstract][Full Text] [Related]
15. Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review).
Rawat SS; Viard M; Gallo SA; Rein A; Blumenthal R; Puri A
Mol Membr Biol; 2003; 20(3):243-54. PubMed ID: 12893532
[TBL] [Abstract][Full Text] [Related]
16. Functional rafts in cell membranes.
Simons K; Ikonen E
Nature; 1997 Jun; 387(6633):569-72. PubMed ID: 9177342
[TBL] [Abstract][Full Text] [Related]
17. Regulation of lipid metabolism by sphingolipids.
Worgall TS
Subcell Biochem; 2008; 49():371-85. PubMed ID: 18751919
[TBL] [Abstract][Full Text] [Related]
18. [Sphingolipids and their medical impact].
Sensken SC; Gräler MH
Dtsch Med Wochenschr; 2009 Feb; 134(6):259-63. PubMed ID: 19180419
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipids and the regulation of the immune response.
Baumruker T; Prieschl EE
Semin Immunol; 2002 Feb; 14(1):57-63. PubMed ID: 11884231
[TBL] [Abstract][Full Text] [Related]
20. On the character and functions of sphingolipids.
Karlsson KA
Acta Biochim Pol; 1998; 45(2):429-38. PubMed ID: 9821873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
